📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nanovi

1.1 - Company Overview

Nanovi Logo

Nanovi

Headquarter: Denmark
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biomaterials-based medical devices for improving guidance and precision in cancer radiotherapy. Offers BioXmark, a liquid fiducial marker that enhances target visibility on imaging for high-precision radiation therapy, including proton beam therapy; and PetXmark, a liquid fiducial marker for dogs and cats to radiographically mark subcutaneous tissue and guide radiotherapy of skin and subcutaneous tumors.

Products and services

  • Advanced Biomaterials-Based Products: Biomaterials-based medical devices developed to raise radiotherapy standards by improving guidance of radiation treatment without altering current routines or equipment, leveraging advanced biomaterials and drug-delivery technologies
  • BioXmark: A proton-compatible liquid fiducial marker that enhances target visibility on imaging to enable high precision cancer radiation therapy, including proton beam therapy
  • PetXmark: A veterinary-specific liquid fiducial marker for dogs and cats that radiographically marks subcutaneous tissue to guide radiotherapy of skin and subcutaneous tumors

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nanovi

ProNova Solutions Logo

ProNova Solutions

HQ: United States Website
  • Description: Provider of compact proton therapy systems and project development services for cancer treatment. Offers the ProNova SC360 with pencil beam scanning and cone-beam CT imaging, leveraging superconducting magnet technology in the cyclotron and treatment gantry, and supports design, construction, equipment installation, commissioning, and clinical start-up of proton therapy centers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProNova Solutions company profile →
T3 Pharmaceuticals Logo

T3 Pharmaceuticals

HQ: Switzerland Website
  • Description: Provider of innovative bacterial cancer therapies using engineered live bacteria to deliver immune-modulating proteins directly to cancer cells and the tumor micro-environment. Offers a proprietary bacterial cancer therapy platform and develops T3P-Y058-739, a lead candidate delivering proteins into solid tumors to induce a specific immune response.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full T3 Pharmaceuticals company profile →
Avacta Logo

Avacta

HQ: United Kingdom Website
  • Description: Provider of technologies, consumables and reagents for life science markets from drug discovery to diagnostics; engaged in research, development, production and delivery of instrumentation and services for biopharmaceutical drug development and clinical diagnostics using biophysical technology. Offerings include the pre|CISION Platform, Affimer Technology, AVA6000, Launch Diagnostics (UK/France), and Coris Bioconcept rapid diagnostic test kits.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avacta company profile →
ESSA Pharma Logo

ESSA Pharma

HQ: Canada Website
  • Description: Provider of small molecule drugs for cancer treatment, with a focus on advanced prostate cancer, developing therapies that selectively block the N-terminal domain of the androgen receptor, a target required for the growth and survival of most prostate cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ESSA Pharma company profile →
Immunocore Logo

Immunocore

HQ: United Kingdom Website
  • Description: Provider of T cell receptor (TCR) bispecific immunotherapies. Offers KIMMTRAK, approved for HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma in various regions including the US and EU. Leverages the ImmTAX platform to develop TCR therapies that activate the immune system to target infected or tumor cells or reduce autoimmune responses, with a clinical pipeline in solid tumors, infectious and autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Immunocore company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nanovi

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nanovi

2.2 - Growth funds investing in similar companies to Nanovi

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nanovi

4.2 - Public trading comparable groups for Nanovi

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nanovi

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nanovi

What does Nanovi do?

Nanovi is a provider of biomaterials-based medical devices for improving guidance and precision in cancer radiotherapy. Offers BioXmark, a liquid fiducial marker that enhances target visibility on imaging for high-precision radiation therapy, including proton beam therapy; and PetXmark, a liquid fiducial marker for dogs and cats to radiographically mark subcutaneous tissue and guide radiotherapy of skin and subcutaneous tumors.

Who are Nanovi's competitors?

Nanovi's competitors and similar companies include ProNova Solutions, T3 Pharmaceuticals, Avacta, ESSA Pharma, and Immunocore.

Where is Nanovi headquartered?

Nanovi is headquartered in Denmark.

How many employees does Nanovi have?

Nanovi has 1,000 employees 🔒.

When was Nanovi founded?

Nanovi was founded in 2010 🔒.

What sector and industry vertical is Nanovi in?

Nanovi is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nanovi

Who are the top strategic acquirers in Nanovi's sector and industry

Top strategic M&A buyers and acquirers in Nanovi's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nanovi?

Top strategic M&A buyers groups and sectors for Nanovi include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nanovi's sector and industry vertical

Which are the top PE firms investing in Nanovi's sector and industry vertical?

Top PE firms investing in Nanovi's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nanovi's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nanovi's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nanovi's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nanovi include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nanovi's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nanovi?

The key public trading comparables and valuation benchmarks for Nanovi include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nanovi for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nanovi with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nanovi's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nanovi with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nanovi's' sector and industry vertical?

Access recent funding rounds and capital raises in Nanovi's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nanovi